Chemring (LSE:CHG) delivered interim results broadly in line with market expectations for the six months ended 30 April 2026, supported by strong demand across its defence and security businesses. The company ended the period with a record order book valued at £1.4 billion, providing significant visibility over future revenues and underpinning its medium-term growth outlook.
Revenue increased 6.5% year over year to £237.3 million, while the group maintained an operating margin of 10.3%. Although underlying operating profit and earnings per share declined during the period, the board approved a 4% increase in the interim dividend. Net debt rose to £144.5 million as the company continued to invest heavily in capacity expansion and strategic growth initiatives.
Capacity Expansion Programme Gains Momentum
Chemring is continuing to expand production capabilities across its Energetics division, with major projects progressing at facilities in Chicago, Scotland and Norway.
Management believes these investments will help the company meet growing customer demand, particularly as defence budgets increase across a number of key markets. The expansion programme is designed to strengthen Chemring’s ability to support long-term contracts while enhancing operational flexibility.
Roke Secures Early Success in Counter-Drone Market
The company also highlighted progress within its Roke business, which has secured initial domestic and international sales of its newly developed counter-drone technology.
As unmanned aerial systems become increasingly prevalent in modern conflict environments, management sees growing opportunities for advanced detection and defence solutions. Early customer adoption is viewed as a positive step in expanding Roke’s presence within this emerging market segment.
Strong Defence Demand Supports Outlook
Chemring said demand remains particularly robust within its Countermeasures & Energetics division, supported by heightened geopolitical tensions and sustained increases in defence spending globally.
Given current trading conditions and the strength of its order book, the company left full-year guidance unchanged. Management believes its combination of capacity expansion, technology development and long-term customer relationships positions the business for continued growth and value creation over the coming years.
Positive Fundamentals Offset Valuation and Technical Concerns
The company’s outlook is supported by solid operational performance, favourable industry trends and positive commentary surrounding the prospects of its Energetics business.
However, investors continue to weigh valuation considerations, including a relatively high price-to-earnings multiple, alongside weaker technical indicators. While the record order backlog provides confidence in future revenue streams, cash flow pressures associated with ongoing investment programmes remain an area of focus.
More About Chemring
Chemring Group is an international defence, aerospace and security company specialising in countermeasures, energetics, sensors and information systems.
The company operates manufacturing facilities across four countries and employs approximately 2,700 people worldwide. Chemring serves customers in more than 50 countries, providing technologies designed to protect personnel, military platforms, critical missions and sensitive data from evolving security threats.
Leave a Reply